Publications
BDI along with colleagues in the field of diabetes health and mental well being are continuously working on research projects to further improve the lives of people living with diabetes worldwide.
Improved treatment satisfaction with once-weekly insulin icodec compared with once-daily basal insulin in individuals with type 2 diabetes: An analysis of patient-reported outcomes and participant interviews from ONWARDS 2 and 5 and a physician survey from ONWARDS 1
Authors: William Polonsky, Malik Benamar, Lisbeth Carstensen, Melanie Davies, Anders Meller Donatsky, Edward Franek, Monika Kellerer, Athena Philis-Tsimikas, Ronald Goldenberg Abstract Aims: The ONWARDS phase 3a clinical trials evaluated once-weekly insulin icodec (icodec) versus once-daily basal insulin in type 2 diabetes. This analysis investigated the treatment-related experiences of participants from ONWARDS 5 and 2, and physicians from ONWARDS 1. Methods: Patient-reported outcomes
Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes
Authors: Sarah A MacLeish, Korey K Hood, William H Polonsky, Jamie R Wood, Bruce W Bode, Gregory P Forlenza, Lori M Laffel, Bruce A Buckingham, Amy B Criego, Melissa J Schoelwer, Daniel J DeSalvo, Jennifer L Sherr, David W Hansen, Lindsey R Conroy, Lauren M Huyett, Todd E Vienneau, Trang T Ly; Omnipod 5 in Preschoolers Study Group Abstract Aim: Automated
Inadequate insurance coverage for overweight/obesity management
Authors: Eden Miller, Steve Edelman, Carlos Campos, John E Anderson, Christopher G Parkin, William H Polonsky Abstract Objectives: To discuss the social, psychological, and access barriers that inhibit weight loss, and to propose steps and initiatives for addressing the growing obesity epidemic. Study design: Narrative review of the obesity epidemic in the US and associated racial/ethnic and socioeconomic disparities. Methods:
Promoting Self-Management in Adults With Type 2 Diabetes: Development of the Impact of Glucose Monitoring on Self-Management Scale
Authors: Michael Vallis , Lori Berard , Emmanuel Cosson , Finn Boerlum Kristensen, Fleur Levrat-Guillen 5, Nicolas Naiditch, Remi Rabasa-Lhoret , William Polonsky Abstract Objectives: Type 2 diabetes (T2D) management requires behavioural engagement to achieve optimal outcomes and continuous glucose monitoring (CGM) technologies may facilitate self-management. In this study, we describe the development and validation of a self-report instrument, the
Recommendations for Screening and Monitoring the Stages of Type 1 Diabetes in the Immune Therapy Era
Authors: Daniel J Moore, Natasha I Leibel, William Polonsky, and Henry Rodriguez Abstract Type 1 diabetes (T1D) is a complex, chronic autoimmune disease that affects over 1.6 million people in the United States. It is now understood that T1D may be undetected for many years while the disease progresses quietly without producing symptoms. T1D can be identified through diabetes-related autoantibody
Diabetes distress and depression are independently associated with gastrointestinal symptoms in type 2 diabetes in Bangladesh
Authors: M Kamruzzaman, M Horowitz, W H Polonsky, N J Talley, M A Borg, C K Rayner, K L Jones, C S Marathe Abstract Background and aims: Gastrointestinal (GI) symptoms, common in type 2 diabetes (T2D), are typically bothersome, socially embarrassing, and impact negatively on quality of life. They may also contribute to diabetes distress (DD), but this has never
EMBARK: A Randomized, Controlled Trial Comparing Three Approaches to Reducing Diabetes Distress and Improving HbA1c in Adults With Type 1 Diabetes
Authors: Danielle M Hessler, Lawrence Fisher, Susan Guzman, Lisa Strycker, William H Polonsky, Andrew Ahmann, Grazia Aleppo, Nicholas B Argento, Joseph Henske, Sarah Kim, Elizabeth Stephens, Katherine Greenberg, Umesh Masharani Abstract Objective: To compare the effectiveness of three interventions to reduce diabetes distress (DD) and improve HbA1c among adults with type 1 diabetes (T1D). Research design and methods: Individuals with
Towards the standardisation of adult person-reported outcome domains in diabetes research: A Consensus Statement development panel
Authors: Katharine Barnard-Kelly, David Marrero, Maartje de Wit, Frans Pouwer, Kamlesh Khunti, Norbert Hermans, Jessica S Pierce, Lori Laffel, Richard I G Holt, Tadej Battelino, Diana Naranjo, Jacqueline Fosbury, Lawrence Fisher, William Polonsky, et al. Abstract Diabetes is unique among chronic diseases because clinical outcomes are intimately tied to how the person living with diabetes reacts to and implements treatment
Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials
Authors: Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís F Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind ABSTRACT AIMS/HYPOTHESIS: Previous studies have shown that individuals with similar mean glucose levels (MG) or percentage of time in range (TIR) may have different HbA1c values. The aim
Understanding suboptimal insulin use in type 1 and 2 diabetes: a cross-sectional survey of healthcare providers who treat people with diabetes
Authors: Rachel S Newson, Erik Spaepen, Birong Liao, Julie Bower, Indranil Bhattacharya, Esther Artime, William Polonsky Abstract Background: The purpose of this study was to understand the healthcare provider (HCP) perspective on the extent of suboptimal insulin dosing in people with diabetes (PwD), as well as specific challenges and solutions to insulin management. Methods: An online survey of general practitioners
I'm looking for information about...
For People with Diabetes
For Healthcare Professionals
Community Resources
Scales & Measures
Diabetes Distress Assessment
BDI Monthly Events
Publications
BDI along with colleagues in the field of diabetes health and mental well being are continuously working on research projects